(1 reference)-
- 抗原 See all CYFRA21.1 抗体
- CYFRA21.1 (Cytokeratin Fragment Antigen 21-1 (CYFRA21.1))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This CYFRA21.1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA
- 特异性
- Cyfra-21-1, Cytokeratin 19 fragment
- 产品特性
- MAb to Cyfra-21-1
- 纯化方法
- Ion Exchange Chromatography
- 纯度
- > 90 % pure (SDS-PAGE)
- 免疫原
- Soluble cytokeratin antigen fraction purified from human cell line
- 克隆位点
- B974M
- 亚型
- IgG1
- Top Product
- Discover our top product CYFRA21.1 Primary Antibody
-
anti-Cytokeratin Fragment Antigen 21-1 (CYFRA21.1) (AA 244-400) antibody
CYFRA21.1 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- Suitable for use in ELISA and Western blot. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
- 限制
- 仅限研究用
-
- 缓冲液
- PBS, 0.05 % Sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C
- 储存方法
- Store at 2-8 °C.
-
-
: "Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays." in: Biomedicines, Vol. 9, Issue 12, (2021) (PubMed).
-
: "Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays." in: Biomedicines, Vol. 9, Issue 12, (2021) (PubMed).
-
- 抗原
- CYFRA21.1 (Cytokeratin Fragment Antigen 21-1 (CYFRA21.1))
- 别名
- Cyfra-21-1 (CYFRA21.1 产品)
-
You are here:
